Connecticut wants to roll back coverage, and Massachusetts MassHealth now limits weight-loss coverage to Zepbound with prior authorization
Mechanistic Understanding: There is a strong biological rationale based on an understanding of the physiological roles of GLP-1 and GIP on insulin secretion, glucose regulation, and satiety
An additional group was daily treated with GLP-1:GIP and additionally food restricted to match the body weight of mice treated with GLP-1:GIP:Lani (n = 10)
Cigna coverage (until now) was $25/month Wonder whatever happened to Lilly and Novo keeping their end of the bargain in the deal with the White House last year by cutting the prices in lieu of expedited FDA reviews
Kahles F, Liberman A, Halim C, et al
Your dose of thyroid medication is often influenced by body weight, and substantial weight loss can make a previously appropriate dose too strong